Single User License: Injectable Targeted Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
USD 4315.5
Flat 10% Discount!!
Report will be delivered with in 15-20 working days
Free Customization as per your requirement You will get Custom Report at Syndicated Report price
Request Sample
Buy Now
REPORT DESCRIPTION
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of drug’s side-effects and reduced oscillation in circulating drug levels. The most important characteristics of targeted drug delivery system are non-toxic, non-immunogenic, both physically and chemically stable in-vivo and in-vitro and controllable and predictable rate of drug release. Browse Full Report with TOC: http://www.transparencymarketresearch.com/injectable-targeted-therapy.html The various types of delivery vehicles used in injectable targeted therapy are liposomes, micelles, dendrimers, biodegradable particles and artificial DNA nanostructures. The applications of injectable targeted therapy are widely classified such as cardiovascular diseases, respiratory diseases and diabetes, but the primary application of injectable targeted therapy is in oncology. The injectable drugs primary target range included oncology, hormonal imbalances, autoimmune diseases, orphan/rare diseases (Cystic Fibrosis, Ribose-5-phosphate isomerase deficiency or RPI deficiency, Hemophilia and Wilson's disease) and others (allergies, aesthetic treatment hepatitis C and pain management). The major drivers of injectable targeted therapy market are growing prevalence of senile disorders, sedentary lifestyle and increasing prevalence of cancer. According to World Health Organization (WHO), there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide. While in same year 57% (8 million) of new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases occurred in the less developed regions
from African and Asian continent. The prevalence of cancer is expected to increase and predicted to reach 24 million by 2035. North America was observed to be the largest market for injectable targeted therapy as it’s a technologically advanced and premium therapy; the highest clinical research studies on targeted therapy market are going in the U.S. and Canada. Followed by Europe, the novel injectable target therapy is applied in most of the oncology cases in United Kingdom, Germany, France, Italy and Spain. Asia-Pacific and Rest of the World (RoW) consists of most of the emerging markets in the world such as India, China, Brazil and Mexico. The injected targeted therapy market in these geographies is currently at initial stages while in Japan this dosage form was observed to be the therapy of choice in most of the oncology patient treatment. Overall demand for targeted drugs is expected to grow in these regions especially after expected breakthroughs in cardiovascular, respiratory and diabetes applications. The global trend observed in injectable targeted therapy market was increased deals in targeted drug delivery companies and ventures are expected to drive the partnership research programs in this therapy market. Some of the major players in Injectable targeted therapy market are Becton Dickinson, SHL Group, Ypsomed Holding AG, Terumo Medical Corp. , Schott AG, Owen Mumford Ltd and Antares Pharma Inc. Some market players currently researching on this technology are Actavis plc, Astra Zeneca plc, GlaxoSmithKline, Merus Laboratories International Inc., National Cancer Institute, Novartis AG, Amgen, Bristol-Myers Squibb, Unilife Corporation, Ligand Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and others. This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include •
North America
•
Asia Pacific
•
Europe
•
Rest of the World
This report provides comprehensive analysis of •
Market growth drivers
•
Factors limiting market growth
•
Current market trends
•
Market structure
•
Market projections for upcoming years
Reasons for Buying this Report •
This report provides pin-point analysis for changing competitive dynamics
•
It provides a forward looking perspective on different factors driving or restraining market growth
•
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
•
It helps in understanding the key product segments and their future
•
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
•
It helps in making informed business decisions by having complete insights of market and by making indepth analysis of market segments
More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceuticalmarket-reports-1.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse Market Research Blogs: http://www.tmrblog.com/ https://marketingfirmblog.wordpress.com